Targeting CCR8 with anti-CCR8 mAb not only reduced multiclonal Tregs specifically in tumor tissues but also evoked strong anti-tumor immune responses without causing harmful autoimmunity [34, 90, 120, 124]. The gene discussed is CCR8; the disease is Autoimmunity.